Alyeska Investment Group’s ASP Isotopes ASPI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.7M Buy
2,843,503
+151,337
+6% +$891K 0.05% 350
2026
Q1
$11.9M Sell
2,692,166
-2,203,380
-45% -$13M 0.03% 382
2025
Q4
$26.2M Buy
4,895,546
+2,072,851
+73% +$16.5M 0.07% 274
2025
Q3
$27.2M Sell
2,822,695
-1,357,239
-32% -$12.5M 0.08% 250
2025
Q2
$30.8M Buy
+4,179,934
New +$28M 0.11% 215
2025
Q1
Sell
-347,022
Closed -$1.57M 511
2024
Q4
$1.57M Sell
347,022
-400,000
-54% -$2.13M 0.01% 475
2024
Q3
$2.08M Buy
+747,022
New +$1.99M 0.01% 419

Other funds holding ASPI

Alyeska Investment Group's ASPI Position: Q2 2026 in Review

Alyeska Investment Group increased its ASP Isotopes (ASPI) stake by 5.6% in Q2 2026, buying an estimated $891K and bringing the position to 2,843,503 shares worth $17.7M. The position accounts for 0.05% of the portfolio, ranked #350.

Alyeska Investment Group first reported a position in ASPI in Q3 2024 and has held it in 7 quarters since. The position peaked at $30.8M in Q2 2025. 185 funds tracked by Wall St. Rank hold ASPI as of Q2 2026.

  • Alyeska Investment Group held 2,843,503 shares of ASP Isotopes worth $17.7M as of Q2 2026.
  • Alyeska Investment Group bought 151,337 ASP Isotopes shares in Q2 2026, an estimated $891K.
  • ASP Isotopes made up 0.05% of Alyeska Investment Group's portfolio in Q2 2026, its #350 holding.
  • Alyeska Investment Group first reported a position in ASP Isotopes in Q3 2024 and has held it in 7 quarters since.
  • Alyeska Investment Group's ASP Isotopes position peaked at $30.8M in Q2 2025.
  • 185 funds tracked by Wall St. Rank held ASP Isotopes as of Q2 2026.

Based on Alyeska Investment Group's 13F filing for Q2 2026, filed 14 Aug 2026.